Colonics
 
About Me

Colonics resources

Recent Posts
Menu
Calendar
«  May 2012  »
MonTueWedThuFriSatSun
 123456
78910111213
14151617181920
21222324252627
28293031 

Friends
    Links


    Entry 1 of 2381
    Last Page | Next Page
    8/5/2010 - FDA designates XOMA 052 for Behcet's disease treatment
    Posted in Medical News

    XOMA Ltd., a leader in the find and evolvement of llc.cite this source roget's ii: the new lexicon



    if (lexico_globals.googleafc.ads.content.length)
    {
    document.write(lexico_globals.googleafc.ads.contenttop);
    document.write(lexico_globals.googleafc.ads.sponsoredlinks);
    document.write(lexico_globals.googleafc.ads.content[2]);
    document.write("") antibodies, announced that the U.S. Food and Drug supervision has bound for XOMA 052, an preventive to interleukin-1 beta, an orphan drug for the care of Behcet's disease. As before announced, the board for Orphan Medical range of the catalan Medicines Agency has food pyramid the granting of orphan medicinal product designation for XOMA 052 for the same nod in the italian Union.

    More: - Brought to my attention by

    Share |

    Post A Comment! :: Send to a Friend!

    Notify me of followup comments via e-mail.

    Share and enjoy
    • Digg
    • del.icio.us
    • DZone
    • Netvouz
    • NewsVine
    • Reddit
    • Slashdot
    • StumbleUpon
    • Technorati
    • YahooMyWeb